Dr. Blum graduated the medical school from the University of Miami Miller and did her residency at the University of Virginia. A fellowship followed at Vanderbilt University soon after that. She is specialized in Oncology. Dr. Blum has been in practice for more than 11 years and is affiliated with The Ohio State University Wexner Medical Center. During her career, she has also contributed to various publications of medical interest.
University of Miami Miller
University of Virginia
American Board of Internal Medicine - Oncology
Outcomes of Patients With Double-Hit Lymphoma Who Achieve First Complete Remission.
Landsburg, D. J.,Falkiewicz, M. K.,Maly, J.,Blum, K. A.,Howlett, C.,Feldman, T.,Mato, A. R.,Hill, B. T.,Li, S.,Medeiros, L. J.,Torka, P.,Hernandez-Ilizaliturri, F.,Red...; J. Clin. Oncol.. 2017 May 06See more >>
BTK(C481S)-Mediated Resistance to Ibrutinib in Chronic Lymphocytic Leukemia.
Woyach, J. A.,Ruppert, A. S.,Guinn, D.,Lehman, A.,Blachly, J. S.,Lozanski, A.,Heerema, N. A.,Zhao, W.,Coleman, J.,Jones, D.,Abruzzo, L.,Gordon, A.,Mantel, R.,Smith, L....; J. Clin. Oncol.. 2017 Apr 19.See more >>
Extended Treatment with Single-Agent Ibrutinib at the 420 mg Dose Leads to Durable Responses in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma.
Coutré, S. E.,Furman, R. R.,Flinn, I. W.,Burger, J. A.,Blum, K.,Sharman, J.,Jones, J.,Wierda, W.,Zhao, W.,Heerema, N. A.,Johnson, A. J.,Tran, A.,Zhou, C.,Bilotti, E.,J...; Clin. Cancer Res.. 2017 Jan 12.See more >>
American Society of Clinical Oncology
American Society of Hematology